Varicella Zoster Virus Transmission in the Vaccine Era: Unmasking the Role of Herpes Zoster

Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
The Journal of Infectious Diseases (Impact Factor: 6). 03/2012; 205(9):1331-3. DOI: 10.1093/infdis/jis214
Source: PubMed
Download full-text


Available from: Karen C Bloch
  • [Show abstract] [Hide abstract]
    ABSTRACT: Classic viral exanthems, such as measles, rubella, and Fifth disease, have great historical significance and, despite vaccine successes, still occur both in the United States and across the world. Because they are either less commonly seen (e.g., measles) or recognized by pediatricians (e.g., Fifth disease), viral exanthems that present to dermatology clinics are often "atypical" and may cause diagnostic confusion. This article will first review a general approach to the patient with a possible viral exanthem, discuss several current issues germane to "classic" exanthems, and delve into greater detail regarding atypical presentations.
    No preview · Article · Nov 2013 · Dermatologic Therapy
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Varicella is a highly contagious disease caused by primary infection with varicella zoster virus (VZV). VZV infection, as well as varicella vaccination, induces VZV-specific antibody and T-cell-mediated immunity, essential for recovery. The immune responses developed contribute to protection following re-exposure to VZV. When cell-mediated immunity declines, as occurs with aging or immunosuppression, reactivation of VZV leads to herpes zoster (HZ). It has been almost 20 years since universal varicella vaccination has been implemented in many areas around the globe and this has resulted in a significant reduction of varicella-associated disease burden. Successes are reviewed here, whilst emphasis is put on the challenges ahead. Most countries that have not implemented routine childhood varicella vaccination have chosen to vaccinate high-risk groups alone. The main reasons for not introducing universal vaccination are discussed, including fear of age shift of peak incidence age and of HZ incidence increase. Possible reasons for not observing the predicted increase in HZ incidence are explored. The advantages and disadvantages of universal vs targeted vaccination as well as different vaccination schedules are discussed.
    Full-text · Article · Mar 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: : This article discusses the incidence, epidemiology, clinical presentation, diagnosis, and treatment of herpes zoster, complications such as postherpetic neuralgia, and prevention through vaccination. Information on vaccine cost and insurance coverage is provided. Two case studies illustrate varying clinical presentations.
    No preview · Article · Mar 2014 · The Nurse practitioner